Published by Digital Look on 10th April 2017
(ShareCast News) - Shares in Akers Biosciences rose on Monday after the health technology company said it has begun marketing its test for heparin-induced thrombocytopenia (HIT) to some hospitals in Puerto Rico as part of its strategy to accelerate US sales of its product.
URL: http://www.digitallook.com/dl/news/story/25792699/...